PDCD1 and metabolic dysfunction-associated steatohepatitis: It has also been reported that CD8+ PD-1+ T-cells in NASH livers show a lack of immune surveillance and tissue-damaging function, which contribute to the increase in HCC emergence upon anti-PD-1 treatment in a NASH mouse model [40].